chloromethyl dodecanoate CAS NO.61413-67-0
- FOB Price: USD: 236.00-284.00 /Kilogram Get Latest Price
- Min.Order: 50 Metric Ton
- Payment Terms: T/T
- Available Specifications:
99.5%(50-500)Kilogram99.5%(500-1000)Kilogram
- Product Details
Keywords
- aripiprazole lauroxil intermediate chloromethyl dodecanoate
- 99.5% chloromethyl dodecanoate
- biobond chloromethyl dodecanoate
Quick Details
- ProName: chloromethyl dodecanoate
- CasNo: 61413-67-0
- Molecular Formula: C13H25ClO2
- Appearance: Colorless liquid
- Application: 61413-67-0; use the key intermediate ...
- DeliveryTime: 100kg: 20 day
- PackAge: 50kg/bucket
- Port: Shanghai
- ProductionCapacity: 2 Metric Ton/Month
- Purity: 99.5%
- Storage: Protected from light at R.T
- LimitNum: 50 Metric Ton
- Moisture Content: <0.2%
- Impurity: <0.15%
- solvent: <2%
Superiority
The product is the key intermediate for producing the aripiprazole lauroxil. and we have produced it for several times from 1-50 kg per batch with high quality of above 99% purity. At the same time, the related impurities have been studied in detail, each impurity of C10 and C14 acid<0.15%, other single unknow impurity<0.15%.
For the market, the complete CMC file of it can be provide, for example, COA, ROS, simple procedure and etc. The following three points are characteristics of it.
1, very high purity
2, can produce it in large scale
3, can control the product with the C10 and C14 impurities <0.15%.
Details
BioBond (Shanghai) Pharmaceutical Co. Ltd (shorten as “BioBond”) has been Founded by some famous professors from Shanghai Institute of Materia and Medica, CAS to Develop new drug in nervous drug and antitumor areas, Located in Shanghai Zhangjiang Hi-tech Park, Eastern Areas ( named as National Medical Apparatus Park).
BioBond has an excellent team with rich experiences in development of drug including drug synthesis, pharmacology, drug formulation, drug analysis scientists. There are two professors and four Doctors and a lot of masters in BioBond. It has three main business domains:
1, Supply some key intermediates of API for some pharmaceutical company in the API’s GMP system;
2, Serve big pharmaceutical company in China for Pre-clinical research of APIs and overall solutions;
3, Develop new drug including designing and synthesizing new compounds and then testing activity.